SRD5A1 and breast cancer: In patients with breast cancer, the negative correlation between methylation and ESR1 induction of gene expression involved mostly CpGs located at enhancers >1 kbp downstream of the transcription start site [78, 79], corresponding with the location of the intronic enhancer of Srd5a1.